# Ciprofloxacin

NDC: 25021-192
Generic name: ciprofloxacin
Labeler / Manufacturer: Sagent Pharmaceuticals
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20221215

FDA application: ANDA078252

## Active ingredients

- CIPROFLOXACIN: 2 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"25021-192"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=25021-192
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f406e796-17d9-4465-b8a7-00d966a4ba74